Litcius/Paper detail

Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress

Dan Zhao, Chao Xue, Jiaqi Li, Ke Feng, Peng Zeng, Yuanli Chen, Yajun Duan, Shuang Zhang, Xiaoju Li, Jihong Han, Xiaoxiao Yang

2020Biochemical and Biophysical Research Communications45 citationsDOI

Topics & Concepts

CardiotoxicityOxidative stressDoxorubicinSirtuinPharmacologyLactate dehydrogenaseApoptosisSuperoxide dismutaseReactive oxygen speciesAdiponectinSOD2Viability assayEndocrinologyChemistryMedicineInternal medicineBiochemistryToxicityChemotherapyEnzymeInsulin resistanceNAD+ kinaseInsulinChemotherapy-induced cardiotoxicity and mitigationCancer Treatment and PharmacologyCarbon Nanotubes in Composites
Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress | Litcius